百时美施贵宝的动态

Are you ready to take your biologics from concept to clinic? At Just - Evotec Biologics, we understand the unique challenges you face in the journey to first-in-human trials. That’s why we’ve launched our new webpage dedicated to Integrated Services for First-in-Human Biologics. Why choose Just - Evotec Biologics? - Comprehensive support from discovery to clinical trials - Cutting-edge technology and expertise - Tailored solutions to accelerate your development process Visit our new webpage to learn how we can partner with you to bring your innovative therapies to patients faster and more efficiently. Explore our integrated services: https://hubs.ly/Q02ZZ3Gp0 Your discovery: Our dedication. #Biotech #FirstInHuman #ClinicalTrials #Healthcare

Are you ready to take your biologics from concept to clinic? At Just - Evotec Biologics, we understand the unique challenges you face in the journey to first-in-human trials. That’s why we’ve launched our new webpage dedicated to Integrated Services for First-in-Human Biologics. Why choose Just - Evotec Biologics? - Comprehensive support from discovery to clinical trials - Cutting-edge technology and expertise - Tailored solutions to accelerate your development process Visit our new webpage to learn how we can partner with you to bring your innovative therapies to patients faster and more efficiently. Explore our integrated services: https://hubs.ly/Q02ZZvK50 Your discovery: Our dedication. #Biotech #FirstInHuman #ClinicalTrials #Healthcare

???? Highlight of 2024: We are proud to announce that Medrio supported phase 3 or pivotal research for 4 FDA approvals last year, representing 5.2% of all novel drug and biologic device approvals! Our work is helping to bring innovative therapies to market, improving countless lives. Looking ahead to 2025, we remain committed to supporting small and mid-sized businesses on their journey to market. Join us in our mission. Connect with us to learn more about how we can support your clinical trials and bring your innovations to life.

Increíble !!! With around 70% of immune and central nervous system diseases still classified as having unmet medical needs, accelerating the discovery of effective therapies is critical. XtalFold will allow us to leverage structural insights into the entire antibody discovery and optimisation workflow; allowing us to be more efficient in how we select and engineer antibodies with suitable drug-like properties.

A partnership with an eye on the future! UCB and Ailux Biologics are uniting vision and technology to explore the full potential of biologics research. Beyond immediate breakthroughs, this collaboration fosters a forward-thinking approach designed to redefine therapeutic possibilities. Discover how this dual commitment to innovation and patient care aims to create new opportunities in healthcare. Read more https://lnkd.in/e8FEsSGW

Exploring the future of healthcare with the Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) ???? Advancing research, fostering innovation, and ensuring the safe use of biologics and biosimilars for better patient outcomes. Read and learn about it in #ManagedCareMondays! #amcp #pharmacyschool #pharmacists #pharmacystudent #westernuamcp #pharmd

Simple answer to the question (why Biosimilars should be used) added to their high quality

??Just 3 days left until #IgNS2024 kicks off! Are you ready for the most impactful event in Ig therapy and biologics? If you haven’t registered yet, it's not too late! ?? https://lnkd.in/gkRqtPHQ #ConferenceAlert #IgTherapy #HealthcareEducation

Missed our webinar on biologics and healthcare logistics? Nik Lambeth shares insights on how good supply chain design ensures the safe, timely delivery of fragile, high-value therapies. Watch the full discussion and learn ways to meet the challenges of biologics head-on. https://okt.to/KbjvY3